Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Re: uvagrad, milestone:
2
Jan 08, 2008 04:34AM
6
Jan 08, 2008 06:33AM
4
Jan 08, 2008 06:46AM
PS
3
Jan 08, 2008 06:54AM

Jan 08, 2008 07:02AM
5
Jan 08, 2008 07:13AM
1
Jan 08, 2008 07:20AM
4
Jan 08, 2008 07:31AM
1
Jan 08, 2008 07:39AM
5
Jan 08, 2008 07:44AM

Jan 08, 2008 07:45AM

Jan 08, 2008 08:05AM

Jan 08, 2008 08:07AM
1
Jan 08, 2008 08:20AM

Keep in mind that any corporate taxpayer of size effectively keeps two sets of books; one to satisfy IRS, and one for SEC and financial reporting. Differences (mainly re: timing of income and expense booking) between the two result in the creation of deferred tax assets or liabilities on the SEC books. Estimated tax payments relate to the IRS books, but the SEC books will reflect a provision for income tax expense), and it is here that there could perhaps be some useful information. However, I believe the current corporate tax rate is 35%, more or less, for income over $335K, so seeing a tax expense number in the neighborhood of 35% of Q2 income (not considering any loss carryforwards or other book/tax differences) would be expected and not very predictive about total income for the year, IMHO. Estimated tax payments for tax purposes are even less useful.

The above results from "channeling" a prior career, and I now have a splitting headache and must lie down, LOL. Perhaps Fut or Bush can clarify further.

Share
New Message
Please login to post a reply